Philippe Romagnoli

The Multiple Sclerosis Society is an organization that aims to find treatments for everyone affected by multiple sclerosis. The non-profit company is based in London, UK. The British company offers award-winning publications, factsheets, and booklets through their online shop. The society conducts surveys to shape the future direction of MS research, with the latest survey held in 2022 with over 6,500 participants. The company's current focus is on the STARMS trial, which compares HSCT with other highly effective treatments for relapsing MS. The treatment involves using chemotherapy to remove harmful immune cells and regrow the immune system using the patient's own stem cells. Nick Moberly has been the CEO of the company since 2019.

Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland.

Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel.

Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities.

Southcoast Hospitals Group, Inc. provides healthcare services. The company was founded in 1996 and is headquartered in Fall River, MA.

Pittsburgh Life Sciences Green House (PLSG) is a venture capital firm founded in 2002. The firm is headquartered in Pittsburgh, Pennsylvania.

Founded in 2002, PLSG Capital Investment Programs is a venture capital/private equity firm located in Pittsburgh, Pennsylvania.

LifeBond Ltd. engages in the development of medical devices designed to restore and repair tissues to reduce post-operative complications. The company was founded by Nir Mashkif, Orahn Preiss-Bloom and Ishay Attar in 2007 and is headquartered in Caesarea, Israel.

The American Kidney Fund provides treatment and financial assistance to patients with chronic kidney disease. It also provides assistance with expenses that insurance will not cover, such as transportation to dialysis, medications, special diet, kidney donor expenses, and other treatments. It also conducts specialty programs that help patients afford treatment during emergency travel and recover from natural disasters. The company was founded in 1971, and is headquartered in Rockville, MD.

I.B.I Israel Biomedical Innovations Ltd. provides surgical and medical solutions specifically for gynecology, urology and gastroenterology. The company was founded in 2004 and is headquartered in Haogen, Israel.

Symmes Life Care, Inc. provides residential care services. It offers rehabilitation services. The company was founded in 1994 and is headquartered in Lexington, MA.

CRF, Inc. provides electronic Clinical Outcome Assessment (eCOA) solutions. eCOA encompasses PROs (Patient Reported Outcomes), ObsROs (Observer Reported Outcomes), and ClinROs (Clinician or Rater Reported Outcomes). The firm's platforms include TrialStudio, TrialMax, and TrialManager. The company was founded by Timo Ahopelto, Jarkko Joki-Tokola and Jaakko Ollila in 2000 and is headquartered in Plymouth Meeting, PA.

OVVI Diagnostics France SE develops diagnostic tests for cardiovascular diseases. The firm’s technology include MIAtek technology, MIAplex technology and instruments for emergency diagnostic test for cardio-vascular diseases. The company was founded by Petr Nikitin, Jean-Patrick Voisin and Daniel Bernard in 2003 and is headquartered in Paris, France.

Robelga SRL provides business and management advisory services. The private company is based in Uccle, Belgium. The Belgian company was founded in 2008. The CEO is Robert Taub.

Recoly NV operates as a biotech company focusing on the discovery, development and commercialization of drug enhancing technologies that are used to create bio-better drugs. Its pipeline includes multiple products; all based on their proprietary technologies, in different development stages from marketing authorization filing through pivotal to pre-clinical studies. The company was founded by Robert Taub in 1992 and is headquartered in Brussels, Belgium.

HighCape Partners Management LLC (HighCape Partners) is a private equity firm founded in 2013 by Kevin Rakin and Matt Zuga. The firm headquartered in Westport, Connecticut..

UPMC Enterprises (UPMC Enterprises) is a venture capital subsidiary of University of Pittsburgh Medical Center founded in 2014. The firm is headquartered in Pittsburgh, Pennsylvania.

Man & Science NV is a Belgian medical device company that develops a novel, minimally invasive, battery-free neurostimulation system to reduce the pain and frequency of severe headache attacks. The company is based in Mont-Saint-Guibert, Belgium, and has subsidiaries in Norway. The company's therapies allow headache patients to return to a normal, pain-free life. The company's team consists of experienced scientists, engineers, clinical research specialists, business experts, and successful start-up founders and entrepreneurs. The company was founded in 2011 by Robert Taub, and Fabian Suarez Gonzalez has been the CEO of the company since 2022.

Herpain Urbis Retail Holding SA is an investment holding Belgian company. The private company is based in Uccle, Belgium. The company was founded in 2015. Yvan Neirinckx has been the CEO of the company since 2015.

HighCape Capital Acquisition Corp. II operates as a blank check company. Its objective is effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded on February 9, 2021 and is headquartered in New York, NY.